AMB-301

N/A

Report date: 2023/10/26 16:48:42

Base Information

Drug NameAMB-301
Drug Alias NameAMB301
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionSelectin E stimulantsGene transference
TargetsSelectin E
Therapy Area/IndicationsThromboangiitis Obliterans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Miami
China Registration ClassN/A

Develop Information

Active CompaniesAmbulero Inc
Inactive CompaniesN/A
Active IndicationsThromboangiitis Obliterans
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A